News

AB SCIEX Triple Quad 6500 LC-MS/MS Systems are designed to facilitate higher levels of sensitivity and increased limits of quantitation to its bioanalytical services in support of pharmacokinetic

The collaboration will leverage CytomX’s Probody Platform to develop safe and effective antibody-drug conjugates (ADCs). CytomX chief executive officer Sean McCarthy said, "Combining our novel Probody Platform with

Produced in Unit 2 of Rafarma’s Terbuni plant, Ceftriaxone formulated for injections will be packed in 10ml bottles with single gram dosages. With an estimated Ceftriaxone market of

Initial customers have already adopted the system to characterize CTCs for biomarkers such as gene expression, mutations, and chromosomal aberrations. Designed for high sensitivity enrichment of rare cells

Composition of a series of prodrugs activated by HK2 enzyme to deliver a thapsigargin derivative selectively targeting prostate cancers is protected by the patent. GenSpera CEO Craig Dionne

Scheduled to commence operations early in 2016, the new facility will be the first to use mammalian cell culture technology in the production of biopharmaceuticals in China. Set

As a fully-serviced outsourcing partner, NextPharma will offer primary and secondary packaging solutions within the European territory. MPE vice president Toshiaki Mikuni said, "We needed a partner with

The total consideration for acquiring the rights will be funded from existing cash and bank facilities, including a £3.5m drawdown from the group’s £30m acquisition facilities. About $0.3m

Primarily affecting manufacturing operations, the company expects reduction in both personnel and other variable expenses, including the product discontinuances, to yield an annual cost savings of approximately $15.0m.